| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |